Ai Could Improve Allergy Skin Test Accuracy
A new visual Ai agent aims to reduce subjectivity and improve documentation efficiency for clinicians performing skin prick testing.
Tag: AAAAI American Academy of Allergy
All
Latest
Ai Could Improve Allergy Skin Test Accuracy
A new visual Ai agent aims to reduce subjectivity and improve documentation efficiency for clinicians performing skin prick testing.
Read More
Asthma Biologics Not Tied to Increased Respiratory Infections
Biologics including Dupilumab and anti-IL-5 agents were associated with a lower probability of pneumonia within the study.
Read More
GLP-1s Tied to Reduced Asthma Exacerbation in Obese Patients
GLP-1 initiation is associated with a 14.6% reduced risk of asthma exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients.
Read More
Congress Reintroduces Bill to Support Penicillin Allergy Delabeling
The Penicillin Allergy Verification and Evaluation (PAVE) Act fights antimicrobial resistance and improves patient outcomes.
Read More
Child Food Allergies Tied to Risk of Anxiety, Bullying
Many children with food allergies experience psychosocial burdens associated with food-allergy related bullying and anxiety.
Read More
Mepolizumab Reduced Need for Repeat Sinus Surgeries in CRwNP Patients
Patients using mepolizumab (Nucala) experienced significant improvement in nasal polyps, nasal obstruction, smell and overall symptoms.
Read More
Peanut Oral Immunotherapy Using Store-Bought, Home-Measured Products
Oral immunotherapy using store-bought and home-measured peanut products provided significantly higher rates of desensitization compared to peanut avoiders.
Read More
Omalizumab Superior to Oral Immunotherapy in Multi-Food Allergy Treatment
Food allergic patients have better outcomes with omalizumab than oral immunotherapy.
Read More
New Guidance Seeks to Ease Documentation Hurdles for Allergy Shot Claims
Recommendations from ACAAI, AAAAI, and AAOA aim to simplify documentation requirements for allergen immunotherapy claims to prevent undue burden on healthcare providers and ensure timely patient access.
Read More
Early Childhood Daycare Attendance May Reduce Risk of Asthma, Allergies
Research shows children attending daycare had clinically significant lower IgE levels and lower rates of food and perennial aero-allergen sensitization.
Read More
Benralizumab Effective for EGPA Patients
More than half of patients with eosinophilic granulomatosis with polyangiitis (EGPA) achieved remission when treated with benralizumab (Fasenra).
Read More
Neffy Epinephrine Nasal Spray Proves Effective in Anaphylaxis
ARS Pharmaceuticals plans to resubmit its NDA for Neffy following successful clinical trials, with hopes of gaining approval later in the year.
Read More
New Guidelines for Treating Anaphylaxis and Atopic Dermatitis
Two practice parameters from the Joint Task Force for Practice Parameters offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis in pediatric and adult patients.
Read More
No Decline in Asthma Exacerbations
Data presented at AAAAI 62 show that despite numerous treatment options for asthma, patients experience emergency department visits, hospitalizations, or attacks at a rate that has not declined substantially over time.
Read More